A method for producing a fluoropolymer which includes polymerizing a fluoromonomer in an aqueous medium in the presence of a surfactant to provide a fluoropolymer, the surfactant being represented by the general formula (1): CR.sup.1R.sup.2R.sup.4—CR.sup.3R.sup.5—X-A, wherein R.sup.1 to R.sup.5 are each H or a monovalent substituent, with the proviso that at least one of R.sup.1 and R.sup.3 represents a group represented by the general formula: —Y—R.sup.6 and at least one of R.sup.2 and R.sup.3 represents a group represented by the general formula: —X-A or a group represented by the general formula: —Y—R.sup.6; and A is the same or different at each occurrence and is —COOM, —SO.sub.3M, or —OSO.sub.3M. Also disclosed is a surfactant for polymerization represented by the general formula (1), a method for producing a fluoropolymer using the surfactant, a composition including a fluoropolymer and the surfactant and a molded body including the composition.

A method for producing a fluoropolymer which includes polymerizing a fluoromonomer in an aqueous medium in the presence of a surfactant to provide a fluoropolymer, the surfactant being represented by the general formula (1): CR.sup.1R.sup.2R.sup.4—CR.sup.3R.sup.5—X-A, wherein R.sup.1 to R.sup.5 are each H or a monovalent substituent, with the proviso that at least one of R.sup.1 and R.sup.3 represents a group represented by the general formula: —Y—R.sup.6 and at least one of R.sup.2 and R.sup.3 represents a group represented by the general formula: —X-A or a group represented by the general formula: —Y—R.sup.6; and A is the same or different at each occurrence and is —COOM, —SO.sub.3M, or —OSO.sub.3M. Also disclosed is a surfactant for polymerization represented by the general formula (1), a method for producing a fluoropolymer using the surfactant, a composition including a fluoropolymer and the surfactant and a molded body including the composition.

The valve member according to one embodiment of the present disclosure is a resin formed product having a crosslinked ethylene-tetrafluoroethylene copolymer as a main component, and having a crosslinking density of 85.0 mol/m.sup.3 or more calculated from a storage modulus at 300° C.

The valve member according to one embodiment of the present disclosure is a resin formed product having a crosslinked ethylene-tetrafluoroethylene copolymer as a main component, and having a crosslinking density of 85.0 mol/m.sup.3 or more calculated from a storage modulus at 300° C.

A matter-repellent colloid-infused smooth surface (CISS) device has a solid substrate with a smooth surface where a thin coating of a non-volatile lubricating fluid and a plurality of nanoparticles and/or microparticles reside on the surface. The non-volatile lubricating fluid can be a perfluorinated fluid and the nanoparticles and/or microparticles can be polytetrafluoroethylene (PTFE) to provide a slippery surface to a metal, ceramic, glass, or plastic substrate. As needed, the smooth surface of the substrate can be modified with a silylating agent that is miscible with the lubricating fluid to enhance the stability of the coating smooth surface interface. In this manner, tubes, catheters, vials, bottles, or other devices can be imparted with a slippery surface that repels most gases, liquids, and solids.

A matter-repellent colloid-infused smooth surface (CISS) device has a solid substrate with a smooth surface where a thin coating of a non-volatile lubricating fluid and a plurality of nanoparticles and/or microparticles reside on the surface. The non-volatile lubricating fluid can be a perfluorinated fluid and the nanoparticles and/or microparticles can be polytetrafluoroethylene (PTFE) to provide a slippery surface to a metal, ceramic, glass, or plastic substrate. As needed, the smooth surface of the substrate can be modified with a silylating agent that is miscible with the lubricating fluid to enhance the stability of the coating smooth surface interface. In this manner, tubes, catheters, vials, bottles, or other devices can be imparted with a slippery surface that repels most gases, liquids, and solids.

A device for permanent placement across an atrial appendage ostium in a patient includes a support structure having a contracted delivery configuration and an expanded deployed configuration defining a radially enlarged portion to permanently engage an interior wall of the atrial appendage, a membrane attached to the support structure and configured to extend across the ostium of the atrial appendage when the support structure is in the expanded deployed configuration, and a polymer coating disposed on at least one of the support structure and the membrane, the polymer coating including a direct oral anticoagulant (DOAC) dispersed in a polymer.

A device for permanent placement across an atrial appendage ostium in a patient includes a support structure having a contracted delivery configuration and an expanded deployed configuration defining a radially enlarged portion to permanently engage an interior wall of the atrial appendage, a membrane attached to the support structure and configured to extend across the ostium of the atrial appendage when the support structure is in the expanded deployed configuration, and a polymer coating disposed on at least one of the support structure and the membrane, the polymer coating including a direct oral anticoagulant (DOAC) dispersed in a polymer.

An implantable, autonomously growing medical device is disclosed. The device may have an outer, braided outer element that holds an inner core. Degradation and/or softening of the inner core permits the outer element to elongate, allowing the device to grow with surrounding tissue. The growth profile of the medical device can be controlled by altering the shape/material/cure conditions of the inner core, as well as the geometry of the out element.

An implantable, autonomously growing medical device is disclosed. The device may have an outer, braided outer element that holds an inner core. Degradation and/or softening of the inner core permits the outer element to elongate, allowing the device to grow with surrounding tissue. The growth profile of the medical device can be controlled by altering the shape/material/cure conditions of the inner core, as well as the geometry of the out element.